Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Glenmark receives IND application clearance to begin Phase I trial of GBR 1302-BEAT for HER2+ cancer

Go Top